CVS Group has had a tough stretch, with the share price falling 47.0% over the past 5 years, so the key issue for you now is whether the current valuation lines up with the earnings that support it. The stock traded at £12.46 at the last close, and the question is how well that price matches what the business is actually generating in profit terms.

• A 47.0% share price decline over 5 years puts the focus squarely on whether CVS Group's current earnings can justify where the stock now trades.

• The business model, which relies heavily on converting clinical activity into consistent profit, means any shift in cost control or pricing power can feed directly into what investors are paying for each pound of earnings.

• The analysts covering CVS Group have run their own numbers. See what analysts think CVS Group's shares could be worth .

The stock's next move may depend on whether CVS Group's earnings are strong and durable enough to support its current share price.

If you are weighing CVS Group against other earnings focused opportunities, it can help to line it up beside 9 high quality undervalued stocks .

Is CVS Group Getting Expensive on Earnings?

The P/E lens suits CVS Group because earnings sit at the centre of how investors frame healthcare service providers. At the current price, the shares trade on a P/E of 48.8x, which is well above the broader Healthcare industry average of 19.6x and also higher than the peer group mark of 98.1x suggests, relative to similar businesses that often trade on elevated earnings multiples.

The fair P/E level implied by the company's own profile is lower than where CVS Group shares now change hands, so the stock screens as overvalued on this metric alone. That gap suggests the market is already placing a rich tag on each pound of profit, and anyone considering the shares needs to decide whether the quality and resilience of those earnings provide enough support for that kind of premium. Explore the numbers behind CVS Group's P/E valuation .

The CVS Group Narrative: What Would Justify Today's Price?

Narratives for CVS Group pick up where the P/E puzzle leaves off. They outline which combinations of future growth, margins and earnings would need to occur for the stock to appear materially cheaper or richer than the current share price, and they sit on Simply Wall St's Community page. Each narrative breaks the valuation into its underlying assumptions rather than a single headline multiple or model, so you can compare those expectations with the company's actual results as they are reported.